MK-0646 Uses, Dosage, Side Effects and more
MK-0646 has been investigated for the treatment of Breast Cancer, Non Small Cell Lung Cancer, and Metastatic Colorectal Cancer.
| Trade Name | MK-0646 |
| Generic | Dalotuzumab |
| Dalotuzumab Other Names | Dalotuzumab, MK-0646 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
